Lonza Research Solutions eNews
     
     
    Lonza logo  
 

Lonza Research Solutions eNews

  
     
July 2011 Subscribe | Forward to a Friend
 

Lonza is expanding its disease product portfolio to metabolic research. Yield even more biologically relevant results with our new human primary cells from Type 1 and Type 2 diabetic donors. We also have an integrated portfolio of complementary products including transfection systems, gene expression and electrophoresis products, and bioassay kits to provide tested solutions for your experimental design.

Metabolism visual
 
     
 

In this issue

New! Diabetes type I and II primary human cells
Get more biological relevance with human skeletal muscle myoblasts and preadipocytes from diabetic donors.
>more

Free MycoAlert™ mycoplasma detection kit sample*
Reliably detect mycoplasma contamination within 20 min using our MycoAlert™ mycoplasma detection kit.
>more

New! Introducing HT Nucleofector™
Designed for high throughput applications, the HT Nucleofector™ can process up to 384 samples in one minute.
>more

New! Custom plate designer for StellARray® qPCR arrays
Convenient online configuration of custom StellARray® qPCR arrays.
>more

Air liquid interface cell culture made easy
Use our B-ALI™ Medium BulletKit™, ALI-guaranteed human bronchial epithelial cells, and ALI protocol for best results.
>more

Human motor neuron progenitors
Human model with no species extrapolation. To access a sample contact your local sales specialist or drugdiscovery@lonza.com
>more  

White paper

White paper: Data presented at the 2011 American Thoracic Society meeting in Denver, CO, USA. Download the pdf
 

Tech tip of the month

For the latest tips on diabetic cells, view our FAQ database
>more

 

Free webinar


Gene expression tools for biologically relevant results
ics file Tuesday,
September 13, 2011
10 AM CET (Europe) /
9 AM GMT (UK) /
6 PM JST (Japan)

Add to your calendar
ics file
Wednesday,
September 14, 2011
2 PM EST /
11 AM PST (US)

Add to your calendar

>Register

Tradeshows


 		 
 
© Copyright 2011, Lonza Cologne GmbH. All rights reserved.

* Please check terms and conditions of the special offers on the respective website:
MycoAlert™.


  
  You are receiving this e-mail because you subscribed to Lonza Research Solutions eNews on our website. If you no longer wish to receive this e-newsletter, you may click the following link to have your address removed from our subscribers list: Unsubscribe